THE POWER OF PROTEINS IN THE PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY

There has been a rapid growth in the biopharmaceutical industry propelled by the influence of the biotechnology sector, since the FDA approval of the first recombinant human therapeutic protein. This innovation driver and its fast growth has created a need for constant scientific training of engineers, scientists, operators, corporate and sales professionals involved in the discovery and development of biomedicines. With the increasing number of drugs in phase III clinical trials being proteins, the emerging field of proteomics and the advancement of its technological tools would certainly impact the drug targets, strategies and even the economic interests of the pharma and biotech industries. This course, provides the participant with a broad understanding of protein concepts and structure, recombinant protein expression, an introduction to proteomics, its types and applications and the current methodology available to analyze and identify proteins. We will briefly touch on the FDA guidelines for drug development and approval of therapeutic proteins and will discuss a case study of biologicals using the scientific literature.

This course is ideal for undergraduate and graduate students, professionals, technicians, operators, and sales personnel in the biotech and pharma industries who want to expand their current knowledge about the biochemistry of proteins and the field of proteomics.